CD74 and neoplasm: These CD74-ROS1 mutants expressing Ba/F3-bearing mice were treated with various doses of DS-6051b, and tumor growth and phospho-ROS1 were inhibited in the mice xenografts in a dose-dependent manner (Fig. 6a–d).